This page shows the latest ferumoxytol news and features for those working in and with pharma, biotech and healthcare.
Adding Makena into its portfolio will give Amag an opportunity in future to increase sales of its own flagship product Feraheme (ferumoxytol), used to treat iron-deficiency anaemia in patients with
Marketing partner Amag also reports three other hypersensitivity reactions. Takeda has recalled a batch of its anaemia medicine Rienso (ferumoxytol) in Switzerland following four reports of hypersensitivity reactions, including one death.
Meanwhile the SMC's latest round of decisions also saw it back the restricted use of Takeda's treatment for iron deficiency anaemia in chronic kidney disease (CKD) Rienso (ferumoxytol).
318. AMAG Pharmaceuticals/ Takeda. feraheme (ferumoxytol) - for iron deficiency anaemia.
and Feraheme (ferumoxytol) for anaemia associated with chronic renal failure.
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
iron deficiency anaemia treatment Rienso (ferumoxytol) in June.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
2013. The appointment is a return to oncology for Dr Allen following a six-year spell as chief medical officer at AMAG Pharmaceuticals – the developer of Feraheme (ferumoxytol) for the treatment
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...